Food and Drug Administration, Dockets Management Branch, 5630 Fishers Lane - Room 1061- HFA-305, Rockville, MD, 20852; 301-827-6860; Fax 301-827-6870 [E-mail Us]

DOCKETS ENTERED on May 31, 2002

TABLE OF CONTENTS

Hyper links are part of the Docket  title - not all dockets/documents are linked

NOTE:  Documents received by the Dockets Management Branch "MAY" be posted on the Internet. PLEASE DO NOT  include personal identifying information, i.e. date of birth, social security number, etc., in your correspondence.

[FDA DOCKETS PAGE] [FDA HOME PAGE]  [ ITEM CODES ]

 
75N-0183 OTC topical antimicrobial products *
77N-0094 OTC Internal Analgesic, Antipyretic & Antirheumatic Products *
80N-0476 Antifungal Drug Products for OTC Human Use *
81N-0033 Oral Health Care Drug Products for OTC Human Use *
01P-0495 Determine Ultram's safety or effectiveness reasons *
02P-0135 Orally-Administered Levothyroxine Sodium all NDAs & ANDAs *
02P-0191 Request for immediate final approval of tramadol Hydrochlori *
02P-0252 Seek immediate final approval of generic tramadol hydrochlor *

75N-0183 OTC topical antimicrobial products

LET 117 HFC-1 to Purdue Frederick Company Vol#: 175

77N-0094 OTC Internal Analgesic, Antipyretic & Antirheumatic Products

LET 142 Bristol-Myers Squibb Company Vol#: 235

80N-0042 Anticaries Drug Products for OTC Human Use

LET 50 Pfizer, Inc. Vol#: 36

80N-0476 Antifungal Drug Products for OTC Human Use

LET 50 HFC-1 to Purdue Frederick Company Vol#: 23

81N-0033 Oral Health Care Drug Products for OTC Human Use

LET 52 Pfizer, Inc. Vol#: 70

94D-0025 Interim GDL/Labeling Milk & Milk Products from Cows w/rbST

C 8581 Daniela Licata Vol#: 116

98N-1038 Irradiation in the production, processing, &handling of food

EMC 1037 Douglas Holt Vol#: 197

EMC 1038 LJ Fidler Vol#: 197

EMC 1039 Kathleen Cook Vol#: 197

EMC 1040 Consuelo Reyes Vol#: 197

EMC 1041 Janet Hitt Vol#: 197

EMC 1042 Brandon Stratton Vol#: 197

EMC 1043 Candice Barratt Vol#: 197

EMC 1044 Dan Souder Vol#: 197

EMC 1045 Karl Christopher Stirland Vol#: 197

EMC 1046 Jerry Ellis Vol#: 197

EMC 1047 Kevin Muir Vol#: 197

EMC 1048 Grace Ragsdale Vol#: 197

EMC 1049 Heather Duff Vol#: 197

EMC 1050 Ernie Biancarelli Vol#: 197

EMC 1051 Susan Emge Milliner Vol#: 197

EMC 1052 Mr. Jere Dozier Vol#: 197

EMC 1053 Sonya Schwartz Vol#: 197

EMC 1054 John Kesich Vol#: 197

EMC 1055 Jyllian Smolev Vol#: 197

EMC 1056 Russell Lynch Vol#: 197

EMC 1057 Susan Emge Milliner Vol#: 197

EMC 1058 Daniel Butler Vol#: 197

EMC 1059 Jose L. Passalacqua Vol#: 197

EMC 1060 Stephen Moore Vol#: 197

EMC 1061 Carol Lisiewski Vol#: 197

EMC 1062 David Fink Vol#: 197

EMC 1063 Kirk S. Lawrence Vol#: 197

EMC 1064 Nancy Hedrick Vol#: 197

99P-5332 Amend limit Hydrogenated & partially Hydrogenated Menhaden O

EMC 40 D. W. Smith Vol#: 1

01P-0495 Determine Ultram's safety or effectiveness reasons

C 7 Caraco Pharmaceuticals Labs., Ltd. Vol#: 2

02N-0052 Temporary Marketing Premit Applications;Information Collect

N 2 Vol#: 1

02N-0053 State Petitions for Ememption from Preemption;Information

N 2 Vol#: 1

02N-0208 State Enforcement Notifications

N 1 Vol#: 1

02P-0135 Orally-Administered Levothyroxine Sodium all NDAs & ANDAs

M 1 HFD-820 Vol#: 1


02P-0191 Request for immediate final approval of tramadol Hydrochlori

C 3 Caraco Pharmaceuticals Labs., Ltd. Vol#: 1

02P-0252 Seek immediate final approval of generic tramadol hydrochlor

ACK 1 HFA-305 Vol#: 1

CP 1 Caraco Pharms Labs, Ltd. Vol#: 1